By Jason Derry --
Icon plc has announced its acquisition of Prevalere Life Sciences Inc., a move that will expand Icon's bioanalytics and immunoassay business in the United States. Prevalere, identified in the announcement as a wholly owned subsidiary of ORS Labs Inc, is a New York-based contract research organization that provides consulting and testing services for biotechnology and pharmaceutical companies. Icon is a European-based contract research organization that also provides clinical trial services for clients in the biotechnology and pharmaceutical industries, as well as the medical device industry. Icon has agreed to acquire Prevalere for an upfront payment of $35 million, and up to $8.2 million in milestone payments.
Jason Derry, Ph.D., who graduated with honors from DePaul University
College of Law, is a molecular biologist and founding author of Patent Docs.
Comments